Fortress Biotech (FBIO) Other Accumulated Expenses (2011 - 2026)

Fortress Biotech's Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $135000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 91.02% year-over-year to $135000.0; the TTM figure through Dec 2025 stood at $135000.0 (down 91.02% YoY), while the FY2025 annual figure was $135000.0, down 91.02% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $135000.0, roughly flat from $135000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $2.1 million in Q1 2025, with the low at $135000.0 in Q3 2025.
• The 4-year median for Other Accumulated Expenses is $996000.0 (2022), against an average of $873307.7.
• Peak annual rise in Other Accumulated Expenses reached 1213.5% in 2025, while the deepest fall reached 91.02% in 2025.
• Fortress Biotech's Other Accumulated Expenses stood at $996000.0 in 2022, then slumped by 83.63% to $163000.0 in 2023, then jumped by 822.7% to $1.5 million in 2024, then tumbled by 91.02% to $135000.0 in 2025.
• Business Quant data shows FBIO's Other Accumulated Expenses at $135000.0 in Q4 2025, $135000.0 in Q3 2025, and $2.1 million in Q2 2025.